ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

BVXV BiondVax Pharmaceuticals Ltd

1.36
0.00 (0.00%)
25 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
BiondVax Pharmaceuticals Ltd BVXV NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 1.36 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.36 1.36
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
16/4/202416:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/4/202406:00PRNUSScinai to showcase its novel biological local therapeutic..
12/3/202415:17EDGAR2Form SC 13D - General statement of acquisition of beneficial..
12/3/202407:00PRNUSScinai leadership to attend BIO-Europe Spring 2024
13/2/202406:00PRNUSScinai Welcomes Liat Halpert as Head of Business Development..
04/1/202415:01PRNUSScinai Immunotherapeutics Announces Closing of Exercise of..
20/11/202306:30PRNUSScinai Immunotherapeutics Regains Compliance with Nasdaq's..
07/9/202316:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
06/9/202311:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/9/202310:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/9/202305:00GLOBEBiondVax Pharmaceuticals Ltd. Rebrands as Scinai..
28/8/202315:01EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
27/8/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
24/8/202315:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/8/202305:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/8/202315:16EDGAR2Form F-3 - Registration statement by foreign private issuers
18/8/202309:07EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
14/8/202305:08EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
11/8/202308:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/8/202308:00GLOBEBiondVax Reports Second Quarter Financial Results and..
01/8/202315:01GLOBENasdaq Grants BiondVax Extension to Regain Compliance with..
01/8/202315:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/7/202314:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/7/202307:17GLOBEIBN Announces Latest Episode of The Bell2Bell Podcast..
05/7/202308:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/7/202315:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/7/202315:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/6/202306:00GLOBEBiondVax signs exclusive license agreement for development..

Su Consulta Reciente

Delayed Upgrade Clock